FDA puts drug on fast track to treat secondary AMLJanuary 22, 2015Leukemia, Myelodysplasia, TransplantationPharmacyAML
EC supports continued use of ponatinibJanuary 21, 2015Leukemia, Myelodysplasia, TransplantationPharmacyALLCML
Label changes report new side effects for hematology drugsJanuary 20, 2015AnemiaLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaThrombosisPharmacyTransplantation
NHS cuts 5 blood cancer drugs from CDF, adds 1January 14, 2015Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaPharmacyRelated IssuesCMLNon-Hodgkin Lymphoma
Product gets fast track designation for CTCLJanuary 9, 2015Lymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin Lymphoma
Cord blood product gets orphan designationJanuary 8, 2015AnemiaLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersBlood BankingPediatricsPharmacyTransplantation
CAR T-cell therapy gets orphan designation for DLBCLJanuary 8, 2015Lymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin Lymphoma
Drug gets orphan designation for WMJanuary 4, 2015Lymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin Lymphoma
New data added to obinutuzumab labelJanuary 1, 2015Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin Lymphoma
FDA approves new formulation of drug for ALLDecember 23, 2014Leukemia, Myelodysplasia, TransplantationPediatricsPharmacy